The outer case is mislabeled as 3.0 K, 2.0 Ca instead of 2.0 K, 3.0 Ca.
Take action
Contact the company
📍Recalling firmNipro Renal Soultions USA, Corporation509 Fishing Creek Rd · Lewisberry, PA 17339-9517
✎ GovInfoNow plain-language explainer
Nipro Renal Solutions is recalling Citric Complete Dry Citric Acid Concentrate (Model DCA+225-25) because the outer case incorrectly labels the chemical composition as 3.0 K, 2.0 Ca instead of 2.0 K, 3.0 Ca. This mislabeling could lead to incorrect usage in medical applications where precise chemical ratios are critical. Read more at govinfonow.com/recall/53424-nipro-renal-solutions-citric-complete-dry-citric-acid-concentrate-recall.
“Nipro Renal Solutions Citric Complete Dry Citric Acid Concentrate Recall: Mislabeled.” GovInfoNow, updated August 18, 2026. https://govinfonow.com/recall/53424-nipro-renal-solutions-citric-complete-dry-citric-acid-concentrate-recall. Based on FDA recall #Z-0820-2025 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-0820-2025%22&limit=1).
The FDA announced on Nov. 22, 2024, that Nipro Renal Solutions USA, Corporation is recalling Citric Complete - Dry Citric Acid Concentrate Model Number DCA+225-25 because the outer case is mislabeled with incorrect potassium and calcium levels.
Lot Numbers: NDC4F001, NDC4G006, NDC4H009, NDC4H010
Quantity: 2,810 units
Distribution: US states including AZ, FL, GA, IL, MI, NC, NJ, OH, TN, TX
The hazard
The hazard is that the outer case is mislabeled as 3.0 K, 2.0 Ca instead of 2.0 K, 3.0 Ca.
Context
GovInfoNow's records show Nipro Renal Soultions USA, Corporation has 2 other recalls on record since 2025-04-11. Other recent recalls of similar products include NIPRO Conductivity Solutions Risk Incorrect Dialysate Calibration (2025-12-12), Fresenius Medical Care Bicarby Dialysate Recall: Incorrect Labeling Risk (2026-05-07), and Fresenius Medical Care Citrasate Liquid Acid Concentrate Recall: Blue-Green Discoloration Complaint (2026-07-14).
How to tell if you have this one
Check for the model number DCA+225-25 on the product packaging. Affected lots include NDC4F001, NDC4G006, NDC4H009, and NDC4H010.
Brand
Nipro Renal Solutions
Category
Medical device
Based on the official FDA remedy
What to do — step by step
Check Product Label
Verify the model number and lot numbers on the packaging to determine if it is affected.
Where it went and when
Where it was distributed
Distributed in 10 states.
Listed by the agency
Not listed
FDA distribution: “US distribution to states of: AZ, FL, GA, GA, IL, MI, NC, NJ, OH, TN, TX.” States read from FDA’s own wording; “not listed” means the notice does not name it.
States: Arizona, Florida, Georgia, Illinois, Michigan, New Jersey, North Carolina, Ohio, Tennessee, Texas.
Recall timeline
FDA published this recall 54 days after the firm started it.
1Firm started the recall
2FDA classified it Class II
3Published in FDA’s Enforcement Report
Dates from the agency record only; steps without a date are left out.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
Official source: FDA Recall #Z-0820-2025 (November 22, 2024) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-0820-2025 to see it in context.
Plain-language summary written by qwen3:4b on August 18, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.